|
Rank | Article | Title | Journal | Citation | REF |
|
1st | Grasselli G. [35] | Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. | Journal of the American Medical Association | 2596 | [35] |
2nd | Helms J. [36] | High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study | Intensive Care Medicine | 1305 | [36] |
3rd | Docherty A.B. [37] | Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study | The BMJ | 1263 | [37] |
4th | Grasselli G. [38] | Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy | JAMA - Journal of the American Medical Association | 1082 | [38] |
5th | Petrilli C.M. [39] | Factors associated with hospital admission and critical illness among 5279 people with Coronavirus disease 2019 in new York City: prospective cohort study | The BMJ | 1068 | [39] |
6th | Lodigiani C. [40] | Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. | Thrombosis Research | 1001 | [40] |
7th | Kong M. [41] | Multisystem inflammatory syndrome in U.S. children and adolescents | New England Journal of Medicine | 935 | [41] |
8th | Alhazzani W. (2020) | Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) | Intensive Care Medicine | 918 | |
9th | Llitjos J.-F. (2020) | High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients | Journal of Thrombosis and Haemostasis | 601 | |
10th | Liang W. (2020) | Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19 | JAMA Internal Medicine | 537 | |
11th | Cook T.M. (2020) | Consensus guidelines for managing the airway in patients with COVID-19: guidelines from the difficult airway society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists | Anaesthesia | 454 | |
12th | Pereira M.R. (2020) | COVID-19 in solid organ transplant recipients: initial report from the US epicenter | American Journal of Transplantation | 419 | |
13th | Cai Q. (2020) | COVID-19: abnormal liver function tests | Journal of Hepatology | 390 | |
14th | White D.B. (2020) | A framework for rationing ventilators and critical care beds during the COVID-19 pandemic | JAMA - Journal of the American Medical Association | 380 | |
15th | Spiezia L. (2020) | COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure | Thrombosis and Haemostasis | 365 | |
16th | Lippi G. (2020) | Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis | Progress in Cardiovascular Diseases | 365 | |
17th | Dowd J.B. (2020) | Demographic science aids in understanding the spread and fatality rates of COVID-19 | Proceedings of the National Academy of Sciences of the United States of America | 362 | |
18th | Murthy S. (2020) | Care for Critically ill Patients with COVID-19. | JAMA - Journal of the American Medical Association | 361 | |
19th | Spyropoulos A.C. (2020) | Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19 | Journal of Thrombosis and Haemostasis | 334 | |
20th | Brenner E.J. (2020) | Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry | Gastroenterology | 330 | |
|